Digital tools to boost HPV vaccination intentions among Nigerian caregivers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares five digital content formats delivered online to Nigerian parents of unvaccinated girls aged 9-14. The goal is to see which approach most effectively increases parents' stated intention to have their daughters receive the HPV vaccine, measured immediately and after one week. Interventions include a motivational interviewing–style chatbot, a pre-bunking game against misinformation, short edutainment videos, standard informational infographics, and a control with unrelated health content. The study focuses on scalable, low-cost digital strategies that could be deployed via mobile phones and other online platforms. Primary findings will inform how best to tailor vaccine messaging to reduce parental hesitancy in this context.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Parent or primary caregiver of at least one girl aged 9-14 years
* Parent states "no" or "unsure" to question asking if eligible daughter has received any doses of the HPV vaccine
* Provides informed consent to participate

Exclusion Criteria:

* Parent or caregiver of a girl who has already received one or more doses of the HPV vaccine
* Does not meet age eligibility criteria for an eligible daughter
* Fails Attention Checks

Where it's running

• Online study
  Lagos, Nigeria Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Can people collect their own vaginal sample for HPV testing as well as clinician collection for comparison?

  This study tests whether individuals can correctly use a self-collection device to gather a vaginal sample for high-risk HPV screening and whether the self-collected sample agrees with clinician-collected samples.

  Recruiting at 11 sites Mel Mont Medical · Phoenix, Arizona and 10 other locations · NCT07758140

• Two-probe thermal ablation for cervical precancer in WLWH in South Africa

  This study tests whether using two probes for thermal ablation is safer or more effective than one probe for treating cervical precancer in women living with HIV in South Africa.

  Recruiting Fred Hutchinson Cancer Center · Durban · NCT07645378

• Two-probe thermal ablation for cervical precancer in WLWH in Zimbabwe

  This study tests whether using two TA probes (endocervical and ectocervical) is better than one probe for treating cervical precancer in women living with HIV in Zimbabwe.

  Recruiting Fred Hutchinson Cancer Center · Harare · NCT07645352

• HPV monitoring after chemoradiotherapy for cervical cancer

  This project will test whether HPV detected on cervical swabs and in blood can find cancer recurrence in people with stage IB–IVA cervical cancer after curative chemoradiotherapy.

  Recruiting General University Hospital, Prague · Prague · NCT07493928

• Two-probe thermal ablation for cervical precancer in HIV+ women in Kenya

  This study tests whether using two probes for thermal ablation is more effective and acceptable than one probe for treating cervical precancer in women living with HIV in Kenya.

  Recruiting Fred Hutchinson Cancer Center · Nairobi · NCT07468695

• Self-swab versus clinician-collected HPV screening for vulnerable women in Reunion

  This study tests whether self-collected swabs work as well and feel as acceptable as clinician-collected swabs for HPV screening in vulnerable women aged 30–65.

  Recruiting at 2 sites Centre Hospitalier Universitaire de la Réunion · Saint-Paul and 1 other locations · NCT07438080

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.